Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer Screening.

Autor: Roberts MC; National Cancer Institute, Rockville, MD, USA. megan.roberts@unc.edu., Seaman EL; National Cancer Institute, Rockville, MD, USA., Klein WMP; National Cancer Institute, Rockville, MD, USA., Ferrer RA; National Cancer Institute, Rockville, MD, USA., Han PKJ; Maine Medical Center Research Institute, Scarborough, ME, USA., Katki HA; National Cancer Institute, Rockville, MD, USA., Land SR; National Cancer Institute, Rockville, MD, USA., Liotta RA; Department of Radiology, Walter Reed National Military Medical Center, Bethesda, MD, USA.; Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Nations JA; Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Peterson PG; Department of Radiology, Walter Reed National Military Medical Center, Bethesda, MD, USA.; Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Jazyk: angličtina
Zdroj: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2022 Oct; Vol. 37 (5), pp. 1438-1445. Date of Electronic Publication: 2021 Mar 09.
DOI: 10.1007/s13187-021-01977-5
Abstrakt: Researchers at the NCI have developed the Risk-Based NLST Outcomes Tool (RNOT), an online tool that calculates risk of lung cancer diagnosis and death with and without lung cancer screening, and false-positive risk estimates. This tool has the potential to facilitate shared decision making for screening. The objective of this study was to examine how current heavy and former smokers understand and respond to personalized risk estimates from the RNOT. Individuals who were eligible for lung cancer screening and were visiting Walter Reed National Military Medical Center were invited to participate in a semi-structured interview to assess their experiences with and perceptions of the RNOT. Results were analyzed using template analysis. Participants found their risk of lung cancer death to be lower than anticipated and were confused by changes in risk for lung cancer diagnosis with and without screening. Most participants indicated that the RNOT would be helpful in making screening decisions, despite reporting that there was no maximum risk for a false positive that would lead them to forgo lung cancer screening. Participants provided actionable needs and recommendations to optimize this tool. Risk-based screening tools may enhance shared decision making. The RNOT is being updated to incorporate these findings.
(© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.)
Databáze: MEDLINE
Externí odkaz: